1143 related articles for article (PubMed ID: 7834749)
1. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
Miyashita T; Reed JC
Cell; 1995 Jan; 80(2):293-9. PubMed ID: 7834749
[TBL] [Abstract][Full Text] [Related]
2. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
3. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter.
Thornborrow EC; Manfredi JJ
J Biol Chem; 2001 May; 276(19):15598-608. PubMed ID: 11278953
[TBL] [Abstract][Full Text] [Related]
5. Design of artificial transcription factors to selectively regulate the pro-apoptotic bax gene.
Falke D; Fisher M; Ye D; Juliano RL
Nucleic Acids Res; 2003 Feb; 31(3):e10. PubMed ID: 12560513
[TBL] [Abstract][Full Text] [Related]
6. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
Chen J; Lin J; Levine AJ
Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
[TBL] [Abstract][Full Text] [Related]
7. Identification of a p53-dependent negative response element in the bcl-2 gene.
Miyashita T; Harigai M; Hanada M; Reed JC
Cancer Res; 1994 Jun; 54(12):3131-5. PubMed ID: 8205530
[TBL] [Abstract][Full Text] [Related]
8. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
Kong XT; Gao H; Stanbridge EJ
J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
[TBL] [Abstract][Full Text] [Related]
10. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes.
Thornborrow EC; Patel S; Mastropietro AE; Schwartzfarb EM; Manfredi JJ
Oncogene; 2002 Feb; 21(7):990-9. PubMed ID: 11850816
[TBL] [Abstract][Full Text] [Related]
11. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
12. The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53.
Schmidt T; Körner K; Karsunky H; Korsmeyer S; Müller R; Möröy T
Cell Death Differ; 1999 Sep; 6(9):873-82. PubMed ID: 10510469
[TBL] [Abstract][Full Text] [Related]
13. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
14. Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast.
Flaman JM; Robert V; Lenglet S; Moreau V; Iggo R; Frebourg T
Oncogene; 1998 Mar; 16(10):1369-72. PubMed ID: 9546439
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.
Ludes-Meyers JH; Subler MA; Shivakumar CV; Munoz RM; Jiang P; Bigger JE; Brown DR; Deb SP; Deb S
Mol Cell Biol; 1996 Nov; 16(11):6009-19. PubMed ID: 8887630
[TBL] [Abstract][Full Text] [Related]
16. Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.
Perez-Sanchez C; Budhram-Mahadeo VS; Latchman DS
Nucleic Acids Res; 2002 Nov; 30(22):4872-80. PubMed ID: 12433990
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
Deb S; Jackson CT; Subler MA; Martin DW
J Virol; 1992 Oct; 66(10):6164-70. PubMed ID: 1356162
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53.
Sala A; Casella I; Grasso L; Bellon T; Reed JC; Miyashita T; Peschle C
Cancer Res; 1996 May; 56(9):1991-6. PubMed ID: 8616838
[TBL] [Abstract][Full Text] [Related]
19. Position and orientation independent transactivation by c-Myc.
Packham G; Bello-Fernandez C; Cleveland JL
Cell Mol Biol Res; 1994; 40(7-8):699-706. PubMed ID: 7787888
[TBL] [Abstract][Full Text] [Related]
20. The bradykinin type 2 receptor is a target for p53-mediated transcriptional activation.
Saifudeen Z; Du H; Dipp S; El-Dahr SS
J Biol Chem; 2000 May; 275(20):15557-62. PubMed ID: 10748162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
